Considering that GSCs give rise to faster cycling bulk tumor cells, we further speculate that the observed moderate in vitro inhibition of GSC self-renewal by Grm3 inhibition may still exert relevant long-term effects on overall tumor growth. The gene discussed is GRM3; the disease is neoplasm.